XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2023
Revenue.  
Summary of revenue disaggregated by product

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2023

2022

2023

2022

Revenue

Lymphedema products

$

62,506

$

54,214

$

172,257

$

146,502

Airway clearance products

7,080

11,048

24,514

26,383

Total

$

69,586

$

65,262

$

196,771

$

172,885

Percentage of total revenue

Lymphedema products

 

90%

 

83%

 

88%

 

85%

Airway clearance products

10%

17%

12%

15%

Total

 

100%

 

100%

 

100%

 

100%

Summary of revenue by channel

Three Months Ended

Nine Months Ended

September 30,

September 30,

(In thousands)

    

2023

2022

2023

2022

Private insurers and other payers

$

39,376

$

36,188

$

101,300

$

97,726

Veterans Administration

7,259

6,755

20,203

19,118

Medicare

15,871

11,271

50,754

29,658

Durable medical equipment distributors

7,080

11,048

24,514

26,383

Total

$

69,586

$

65,262

$

196,771

$

172,885

Sales-type lease revenue and the associated cost of goods sold

Three Months Ended September 30,

Nine Months Ended September 30,

(In thousands)

2023

2022

2023

2022

Sales-type lease revenue

$

10,720

$

9,717

$

25,312

$

24,905

Cost of sales-type lease revenue

 

3,211

 

2,992

 

9,122

 

7,640

Gross profit

$

7,509

$

6,725

$

16,190

$

17,265